|
- Home | Biogen
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities
- Biogen US Medical Information Website
This website provides US healthcare professionals (HCPs) with evidence-based scientific responses to unsolicited medical questions about Biogen products The information is provided for educational purposes only and is not intended to be promotional nor provide medical advice
- Students Graduates | Biogen
Biogen is developing the next generation of talent in biotech Hear from students as they discuss their internship experience, what attracted them to Biogen, and how they felt supported by their teams
- New Higher Dose Nusinersen Efficacy and Safety Data Presented at World . . .
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities
- Annual Reports - Biogen
The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts
- Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at . . .
About Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities
- Inicio | Biogen
Biogen es una empresa líder en biotecnología a nivel global, pionera en la ciencia y que impulsa innovaciones para enfermedades complejas y devastadoras
- FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen . . .
“We are pleased to announce that our applications for the higher dose regimen of nusinersen are now under review in the US and Europe,” said Stephanie Fradette, Pharm D , Head of the Neuromuscular Development Unit at Biogen
|
|
|